Neonatal survival and disability rate at age 18 months for infants born between 23 and 28 weeks of gestation - 11/09/11
Abstract |
OBJECTIVE: Our purpose was to determine gestational age - specific outcomes of infants born in a period of surfactant use. STUDY DESIGN: All 465 consecutive births between 23 and 28 weeks' gestation in a tertiary center from 1987 to 1992 were analyzed prospectively. At 18 months' corrected age, 217 of 254 (85%) survivors were evaluated. RESULTS: From 1987 and 1988 to 1991 and 1992 there was an increase in survival for infants born at 24 weeks (from 0% to 33%, p = 0.17), 25 to 26 weeks (38% to 71%, p < 0.005), and 27 to 28 weeks (66% to 84%, p < 0.05). At each weekly interval from 24 to 28 weeks of gestation the respective incidence of normality was 44%, 71%, 57%, 76%, and 72% (not significant) and the respective mean developmental quotient was 91 ± 17, 89 ± 25, 90 ± 24, 96 ± 15, and 96 ± 14 (not significant). CONCLUSIONS: Gestational age was strongly associated with outcome in terms of survival. Overall, 70% of children followed up were developing within the normal range. (AM J OBSTET GYNECOL 1996;174:833-8.)
Le texte complet de cet article est disponible en PDF.Keywords : Extremely low gestational age, neonatal outcome, premature infants, very-low-birth-weight infants
Plan
 | From the Neonatal Service and Research Center, Hôpital Ste-Justine, and the Department of Pediatrics, Université de Montréal. |
| Reprint requests: Francine Lefebvre, MD, Hôpital Ste-Justine, 3175 Chemin Côte Ste-Catherine, Montréal, Québec, Canada H3T 1C5. |
 | 0002-9378/96 $5.00 + 0 6/1/68367 |
Vol 174 - N° 3
P. 833-838 - mars 1996 Retour au numéro
Article précédent
- Is fetal neurologic and physical development accelerated in preeclampsia?
- Radha S. Chari, Steven A. Friedman, Eyal Schiff, Antoine Y. Frangieh, Baha M. Sibai
- Second-trimester echogenic bowel and intraamniotic bleeding: Association between fetal bowel echogenicity and amniotic fluid spectrophotometry at 410 nm
- Waldo Sepulveda, Rosemary Reid, Peter Nicolaidis, Oonagh Prendiville, Richard S. Chapman, Nicholas M. Fisk
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?